[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100643877":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":34,"locations":40,"responsibleParty":134,"collaborators":25,"id":136,"slug":25,"hasResults":137,"nctId":138,"briefTitle":139,"officialTitle":140,"acronym":141,"eligibilityCriteria":142,"healthyVolunteers":137,"sex":143,"minAge":144,"maxAge":25,"enrollmentInfo":145,"targetDuration":25,"studyType":148,"phases":149,"briefSummary":151,"conditions":152,"keywords":25,"overallStatus":155,"whyStopped":25,"lastUpdateSubmitDate":156,"lastUpdatePostDateStruct":157,"startDateStruct":160,"completionDateStruct":162,"leadSponsor":164,"locationsCount":165},{"fullName":5,"class":6},"Novo Nordisk A\u002FS","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Zenagamtide","EXPERIMENTAL","Participants will be randomized to receive 1 out of 3 different dose levels subcutaneously once weekly.",[13],"Drug: Zenagamtide",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","Participants will receive placebo matched to Zenagamtide subcutaneously once weekly.",[19],"Drug: Placebo ( matched to Zenagamtide)",[21,26],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Zenagamtide will be administered subcutaneously using PDS290 pre-filled pen-injectors to one of the body parts: thigh, abdomen or upper arm.",[9],null,{"type":22,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Placebo ( matched to Zenagamtide)","Placebo matched to Zenagamtide will be administered subcutaneously using PDS290 pre-filled pen-injectors to one of the body parts: thigh, abdomen or upper arm.",[15],[31],{"name":32,"affiliation":5,"role":33},"Clinical Transparency (dept. 2834)","STUDY_DIRECTOR",[35],{"name":36,"role":37,"phone":38,"phoneExt":25,"email":39},"Novo Nordisk","CONTACT","(+1) 866-867-7178","clinicaltrials@novonordisk.com",[41,54,63,68,77,87,97,106,113,122,128],{"facility":42,"status":25,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":25},"Nirmal Hospital Pvt. Ltd.","Surat","Gujarat","395002","India","IN",{"type":49,"coordinates":50},"Point",[51,52],72.83023,21.19594,{"lat":52,"lon":51},{"facility":55,"status":25,"city":56,"state":44,"zip":57,"country":46,"countryCode":47,"cosmosGeoPoint":58,"geoPoint":62,"contacts":25},"SSG Hospital, Baroda","Vadodara","390001",{"type":49,"coordinates":59},[60,61],73.20812,22.29941,{"lat":61,"lon":60},{"facility":64,"status":25,"city":65,"state":66,"zip":67,"country":46,"countryCode":47,"cosmosGeoPoint":25,"geoPoint":25,"contacts":25},"Shree Mahalaxmi DIATONE Institute","Kohlapur","Maharashtra","416001",{"facility":69,"status":25,"city":70,"state":66,"zip":71,"country":46,"countryCode":47,"cosmosGeoPoint":72,"geoPoint":76,"contacts":25},"Excel Endocrine Centre","Kolhāpur","416008",{"type":49,"coordinates":73},[74,75],74.23167,16.69563,{"lat":75,"lon":74},{"facility":78,"status":25,"city":79,"state":80,"zip":81,"country":46,"countryCode":47,"cosmosGeoPoint":82,"geoPoint":86,"contacts":25},"Maulana Azad Medical College","Delhi","New Delhi","110002",{"type":49,"coordinates":83},[84,85],77.23149,28.65195,{"lat":85,"lon":84},{"facility":88,"status":25,"city":89,"state":90,"zip":91,"country":46,"countryCode":47,"cosmosGeoPoint":92,"geoPoint":96,"contacts":25},"Diabetes Research Center, Hyderabad","Hyderabad","Telangana","500 082",{"type":49,"coordinates":93},[94,95],78.45636,17.38405,{"lat":95,"lon":94},{"facility":98,"status":25,"city":99,"state":25,"zip":100,"country":46,"countryCode":47,"cosmosGeoPoint":101,"geoPoint":105,"contacts":25},"SMS Hospital","Jaipur","302004",{"type":49,"coordinates":102},[103,104],75.78781,26.91962,{"lat":104,"lon":103},{"facility":107,"status":25,"city":108,"state":109,"zip":110,"country":111,"countryCode":112,"cosmosGeoPoint":25,"geoPoint":25,"contacts":25},"OCROM Clinic_Internal medicine","Suita-shi","Osaka","565-0853","Japan","JP",{"facility":114,"status":25,"city":115,"state":25,"zip":116,"country":111,"countryCode":112,"cosmosGeoPoint":117,"geoPoint":121,"contacts":25},"Tokyo-Eki Center-building Clinic_Internal Medicine","Tokyo","103-0027",{"type":49,"coordinates":118},[119,120],139.69171,35.6895,{"lat":120,"lon":119},{"facility":123,"status":25,"city":115,"state":25,"zip":124,"country":111,"countryCode":112,"cosmosGeoPoint":125,"geoPoint":127,"contacts":25},"Fukuwa Clinic_Internal Medicine","104-0031",{"type":49,"coordinates":126},[119,120],{"lat":120,"lon":119},{"facility":129,"status":25,"city":115,"state":25,"zip":130,"country":111,"countryCode":112,"cosmosGeoPoint":131,"geoPoint":133,"contacts":25},"ToCROM Clinic_Internal Medicine","160-0008",{"type":49,"coordinates":132},[119,120],{"lat":120,"lon":119},{"type":135,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100643877",false,"NCT07668401","AMAZE 13: A Research Study Investigating How Well the Medicine Zenagamtide Helps People in Asia With Excess Body Weight Lose Weight","Efficacy and Safety of Zenagamtide s.c. Once-weekly in Asian Participants With Overweight or Obesity (AMAZE 13)","AMAZE 13","Inclusion Criteria:\n\n* Male or female (sex assigned at birth, inclusive of all gender identities).\n* Age 18 years or above at the time of signing the informed consent\n\nExclusion Criteria:\n\n* Glycated haemoglobin (HbA1c) ≥ 6.5% (48 mmol\u002Fmol) as measured by the central laboratory at screening.\n* History of type 1 or type 2 diabetes mellitus.\n* Treatment with glucagon-like-peptide-1 (GLP-1) receptor agonists (RA), dual GLP-1\u002Fgastric inhibitory peptide (GIP) RAs (or any other GLP-1 based treatment) or amylin analogues before screening.","ALL","18 Years",{"count":146,"type":147},400,"ESTIMATED","INTERVENTIONAL",[150],"PHASE3","The purpose of this clinical study is to find out if zenagamtide is safe and effective for treating people who have excess body weight. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get zenagamtide (the treatment being tested) or placebo (a treatment that has no active medicine in it). Which treatment participants get is decided by chance.",[153,154],"Obesity","Overweight","NOT_YET_RECRUITING","2026-06-19",{"date":158,"type":159},"2026-06-25","ACTUAL",{"date":161,"type":147},"2027-01-07",{"date":163,"type":147},"2029-01-11",{"name":5,"class":6},11]